Table 4.
Cytokine vs. Modulator | Low/Low | Low/High | High/Low | High/High |
---|---|---|---|---|
IL-1β vs. IL-1Ra | ||||
# cases/# controls | 72/139 | 39/85 | 42/71 | 77/137 |
OR (95% CI) | 1.0 (ref) | 0.91 (0.57, 1.47) | 1.15 (0.71, 1.85) | 1.09 (0.73, 1.64) |
p-value | 0.71 | 0.57 | 0.67 | |
IL-1β vs. sIL-1Rll | ||||
# cases/# controls | 46/105 | 65/119 | 70/109 | 49/99 |
OR (95% CI) | 1.0 (ref) | 1.20 (0.76, 1.92) | 1.43 (0.90, 2.27) | 1.11 (0.68, 1.81) |
p-value | 0.43 | 0.13 | 0.69 | |
IL-2 vs. sIL-2Ra | ||||
# cases/# controls | 48/118 | 59/107 | 63/99 | 60/108 |
OR (95% CI) | 1.0 (ref) | 1.36 (0.85, 2.19) | 1.56 (0.98, 2.47) | 1.36 (0.85, 2.16) |
p-value | 0.20 | 0.06 | 0.20 | |
IL-4 vs. sIL-4R | ||||
# cases/# controls | 61/121 | 44/103 | 53/95 | 72/113 |
OR (95% CI) | 1.0 (ref) | 0.85 (0.53, 1.36) | 1.11 (0.70, 1.76) | 1.28 (0.84, 1.97) |
p-value | 0.50 | 0.65 | 0.25 | |
IL-6 vs. sIL-6R | ||||
# cases/# controls | 52/116 | 51/110 | 68/94 | 59/112 |
OR (95% CI) | 1.0 (ref) | 1.05 (0.66, 1.68) | 1.65 (1.05, 2.61) | 1.19 (0.76, 1.89) |
p-value | 0.84 | 0.03 | 0.45 | |
IL-12p70 vs. IL-12p40 | ||||
# cases/# controls | 49/129 | 54/100 | 58/96 | 69/107 |
OR (95% CI) | 1.0 (ref) | 1.46 (0.92, 2.34) | 1.62 (1.01, 2.58) | 1.74 (1.11, 2.74) |
p-value | 0.11 | 0.04 | 0.02 | |
TNFα vs. sTNF-R1 | ||||
# cases/# controls | 48/137 | 67/83 | 62/85 | 63/127 |
OR (95% CI) | 1.0 (ref) | 2.12 (1.30, 3.45) | 2.13 (1.33, 3.41) | 1.51 (0.95, 2.41) |
p-value | 0.002 | 0.002 | 0.08 | |
TNFα vs. sTNF-R2 | ||||
# cases/# controls | 62/129 | 43/91 | 53/86 | 72/126 |
OR (95% CI) | 1.0 (ref) | 0.98 (0.61, 1.58) | 1.28 (0.81, 2.03) | 1.18 (0.76, 1.82) |
p-value | 0.94 | 0.29 | 0.46 |
Note: Each marker was classified as high or low based on the median value and then four groups were created for each pair. Models are unconditional logistic regression models, adjusted for the matching factors (age, cohort, menopausal status)